ABBV logo

ABBV

AbbVie Inc.

$214.39
-$1.31(-0.61%)
46
Overall
60
Value
36
Tech
44
Quality
How is this score calculated?
Market Cap
$405.55B
Volume
1.23M
52W Range
$181.73 - $244.81
Target Price
$250.90
Order:

Income Statement

MetricTrendChart
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
2025
Dec
REVENUE
Total Revenue
$25.6B$28.2B$32.8B$33.3B$45.8B$56.2B$58.1B$54.3B$56.3B$61.2B
Total Revenue
$25.6B$28.2B$32.8B$33.3B$45.8B$56.2B$58.1B$54.3B$56.3B$61.2B
COST OF GOODS SOLD
Cost of Revenue
$5.8B$7.0B$7.7B$7.4B$15.4B$17.4B$17.4B$20.4B$16.9B$18.2B
GROSS PROFIT
Gross Profit
$19.8B$21.2B$25.0B$25.8B$30.4B$38.8B$40.6B$33.9B$39.4B$43.0B
OPERATING EXPENSES
Operating Expenses
$10.4B$11.6B$18.7B$12.8B$19.1B$20.8B$21.8B$21.1B$30.3B$27.9B
Research & Development
$4.6B$5.3B$10.8B$6.8B$7.8B$8.0B$7.2B$8.5B$15.5B$14.1B
Research Expense
$4.4B$5.0B$10.3B$6.4B$6.6B$6.9B$6.5B$7.7B$12.8B$9.1B
Selling, General & Administrative
$5.9B$6.3B$7.4B$6.9B$11.3B$12.3B$15.3B$12.9B$14.8B$14.0B
Selling & Marketing Expenses
$764.0M$846.0M$1.1B$1.1B$1.8B$2.1B$2.0B$2.2B$2.1B--
General & Administrative Expenses
$5.9B$6.3B$7.4B$6.9B$11.3B$12.3B$15.3B$12.9B$14.8B$14.0B
Promotion & Advertising
$764.0M$846.0M$1.1B$1.1B$1.8B$2.1B--------
Salaries & Wages
$-104.0M$-73.0M$-73.0M$-80.0M$-131.0M$-126.0M--------
Depreciation & Amortization
$425.0M$425.0M$471.0M$464.0M$666.0M$803.0M$778.0M$752.0M$764.0M--
Depreciation & Amortization
$425.0M$425.0M$471.0M$464.0M$666.0M$803.0M--------
Amortization
$28.9B$27.6B$21.2B$18.6B$82.9B$76.0B$67.4B$55.6B$60.1B--
Other Operating Expenses
$-118.0M$-1.8B$500.0M$-890.0M$-91.0M$432.0M$56.0M$-179.0M$-7.0M$-241.0M
OPERATING INCOME
Operating income
$9.4B$9.5B$6.4B$13.0B$11.4B$17.9B$18.1B$12.8B$9.1B$15.1B
EBITDA
$10.1B$10.4B$8.3B$12.3B$12.3B$23.9B$24.2B$16.6B$14.2B$17.4B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$1.0B$1.1B$1.3B$1.8B$2.5B$2.4B$2.2B$1.7B$2.2B$2.6B
Intinc
$-965.0M$-1.0B$-1.1B$-1.5B$-2.3B$-2.4B$-2.0B$540.0M$648.0M$266.0M
Net Non-Operating Interest Income/Expense
$-965.0M$-1.0B$-1.1B$-1.5B$-2.3B$-2.4B$-2.0B$-1.7B$-2.2B$-2.6B
Gain on Sale of Securities
$-252.0M$90.0M----------------
Other Income/Expense
$232.0M$466.0M$18.0M$3.0B$5.6B$2.5B$-3.3B$4.7B$3.2B$5.8B
Other Special Charges
$-232.0M$-466.0M$-18.0M$-3.0B$-5.6B$-2.5B$-2.4B$-4.7B$-3.2B$-5.8B
SPECIAL ITEMS
Restructring And Mn A Income
$52.0M$86.0M$59.0M$219.0M------------
Special Income Charges
$-52.0M$-440.0M$-59.0M$-219.0M------$2.9B$4.6B--
Impairment of Capital Assets
--$354.0M----------------
PRE-TAX INCOME
EBIT
$8.9B$8.9B$6.5B$10.2B$5.9B$15.4B$15.7B$7.9B$5.9B$9.2B
Pre-Tax Income
$7.9B$7.7B$5.2B$8.4B$3.4B$13.0B$13.5B$6.3B$3.7B$6.6B
INCOME TAX
Tax Provision
$1.9B$2.4B$-490.0M$544.0M$-1.2B$1.4B$1.6B$1.4B$-570.0M$2.4B
NET INCOME
Net Income
$6.0B$5.3B$5.7B$7.9B$4.6B$11.5B$11.8B$4.9B$4.3B$4.2B
Net Income (Continuing Operations)
$6.0B$5.3B$5.7B$7.9B$4.6B$11.5B$11.8B$4.9B$4.3B$4.2B
Net Income (Discontinued Operations)
$6.0B$5.3B$5.7B$7.9B$4.6B$11.5B$11.8B$4.9B$4.3B$4.2B
Net Income (Common Stockholders)
$6.0B$5.3B$5.7B$7.9B$4.6B$11.5B$11.8B$4.9B$4.3B$4.2B
Normalized Income
$5.4B$6.1B$4.8B$9.7B$2.2B--------$6.5B
TOTALS
Total Expenses
$16.3B$18.7B$26.4B$20.3B$34.4B$38.2B$39.2B$41.6B$47.2B$46.1B
SHARE & EPS DATA
Average Shares Outstanding
$1.6B$1.6B$1.5B$1.5B$1.7B$1.8B$1.8B$1.8B$1.8B$1.8B
Average Shares Outstanding (Diluted)
$1.6B$1.6B$1.5B$1.5B$1.7B$1.8B$1.8B$1.8B$1.8B$1.8B
Shares Outstanding
$1.6B$1.6B$1.5B$1.5B$1.8B$1.8B$1.8B$1.8B$1.8B$1.8B
Basic EPS
$3.65$3.31$3.67$5.3$2.73$6.48$6.65$2.73$2.4$2.37
Basic EPS (Continuing Operations)
$3.65$3.31$3.67$5.3$2.73$6.48$6.65$2.73$2.4$2.37
Diluted EPS
$3.63$3.3$3.66$5.28$2.72$6.45$6.63$2.72$2.39$2.36
Diluted EPS (Continuing Operations)
$3.63$3.3$3.66$5.28$2.72$6.45$6.63$2.72$2.39$2.36
Dividend Per Share
$2.35$2.63$3.95$4.39$4.84$5.31$5.71$5.99$6.29$6.65
OTHER METRICS
Development Expense
$200.0M$327.0M$424.0M$385.0M$1.2B$1.1B$697.0M$778.0M$2.8B$5.0B
Gain On Sale Of P P E
----------$68.0M--------
Minority Interests
------$-8.2B$-6.0M$-7.0M$-9.0M$-10.0M$-8.0M$-7.0M
Other Gand A
$5.9B$6.3B$7.4B$6.9B$11.3B$12.3B$15.3B$12.9B$14.8B$14.0B
Other Impairment Of Capital Assets
----------$50.0M--------
Rent And Landing Fees
$159.0M$169.0M$161.0M--------------
Restruct
$52.0M$86.0M$59.0M$219.0M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ABBV$214.39-0.6%1.23M
3
4
5
6

Get AbbVie Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.